LOREEV XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loreev Xr, and what generic alternatives are available?
Loreev Xr is a drug marketed by Almatica and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-five patent family members in thirty countries.
The generic ingredient in LOREEV XR is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loreev Xr
A generic version of LOREEV XR was approved as lorazepam by SANDOZ on April 21st, 1987.
Summary for LOREEV XR
International Patents: | 35 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 3,762 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOREEV XR |
What excipients (inactive ingredients) are in LOREEV XR? | LOREEV XR excipients list |
DailyMed Link: | LOREEV XR at DailyMed |
Pharmacology for LOREEV XR
Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for LOREEV XR
US Patents and Regulatory Information for LOREEV XR
LOREEV XR is protected by one US patents.
Patents protecting LOREEV XR
Sustained release formulations of lorazepam
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: ONCE DAILY TREATMENT OF ANXIETY DISORDER IN ADULTS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-001 | Aug 27, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-003 | Aug 27, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-004 | Feb 16, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-002 | Aug 27, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for LOREEV XR
See the table below for patents covering LOREEV XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 2943185 | ⤷ Try a Trial | |
Japan | 6039823 | ⤷ Try a Trial | |
South Korea | 102318274 | ⤷ Try a Trial | |
South Africa | 201505082 | SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM | ⤷ Try a Trial |
Mexico | 2015008756 | FORMULACIONES DE LORAZEPAM DE LIBERACION SOSTENIDA. (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM.) | ⤷ Try a Trial |
South Korea | 20150118119 | 로라제팜의 지속 방출성 제제 (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM) | ⤷ Try a Trial |
Japan | 2016504390 | ロラゼパムの徐放性製剤 | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |